Humacyte, Inc. (HUMA)
0.4744
0.00 (0.00%)
USD |
NASDAQ |
Oct 07, 16:00
0.475
0.00 (0.00%)
After-Hours: 18:51
Humacyte Net Income (Quarterly) : -36.80M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -36.80M |
| March 31, 2026 | -17.62M |
| December 31, 2025 | -24.80M |
| September 30, 2025 | -17.51M |
| June 30, 2025 | -37.66M |
| March 31, 2025 | 36.76M |
| December 31, 2024 | -20.94M |
| September 30, 2024 | -39.20M |
| June 30, 2024 | -56.66M |
| March 31, 2024 | -31.90M |
| December 31, 2023 | -25.11M |
| September 30, 2023 | -26.00M |
| Date | Value |
|---|---|
| June 30, 2023 | -22.71M |
| March 31, 2023 | -36.97M |
| December 31, 2022 | -3.72M |
| September 30, 2022 | -25.28M |
| June 30, 2022 | 36.87M |
| March 31, 2022 | -19.83M |
| December 31, 2021 | 42.58M |
| September 30, 2021 | -31.56M |
| June 30, 2021 | -17.20M |
| March 31, 2021 | -20.30M |
| December 31, 2020 | -16.21M |
| September 30, 2020 | -17.76M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Amgen, Inc. | 2.375B |
| Altimmune, Inc. | -22.82M |
| Protalix Biotherapeutics, Inc. | 3.777M |
| Taysha Gene Therapies, Inc. | -46.64M |
| Agenus, Inc. | -0.567M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.406M |
| Total Expenses (Quarterly) | 37.21M |
| EPS Diluted (Quarterly) | -0.1572 |
| Enterprise Value | 118.92M |
| Gross Profit Margin (Quarterly) | -423.2% |
| Profit Margin (Quarterly) | -9.06K% |
| Earnings Yield | -103.2% |
| Normalized Earnings Yield | -123.23 |